Last reviewed · How we verify
tissue culture media
At a glance
| Generic name | tissue culture media |
|---|---|
| Also known as | (G.2 plus ref. 10132, Vitrolife) |
| Sponsor | The Egyptian IVF-ET Center |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Effects of Relugolix vs Leuprolide on Cardiac Function in Patients With Prostate Cancer (PHASE2)
- A/Texas Flu Challenge (PHASE1)
- Start4All - Start Taking Action for TB Diagnosis (DARE-TB) (NA)
- The Effectiveness of Binaural Beats on Midazolam Requirement During Cesarean Section With Spinal Anesthesia (NA)
- Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years (PHASE4)
- Diffusion MRI for Head and Neck Cancer (NA)
- PVEK Corneal Implant For Treatment of Corneal Edema (PHASE1)
- Evaluation of In-Vitro Cryo Therapeutic Protocols on Human Cell Samples (TWH-CRYO-001) (EARLY_PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- tissue culture media CI brief — competitive landscape report
- tissue culture media updates RSS · CI watch RSS
- The Egyptian IVF-ET Center portfolio CI